Apollo Endosurgery

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch APEN and buy or sell other stocks, options, and ETFs commission-free!

About APEN

Apollo Endosurgery develops medical devices for the diagnosis and treatment of gastrointestinal diseases. The company’s device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. 

CEO
Charles S. McKhann, MBA
CEOCharles S. McKhann, MBA
Employees
281
Employees281
Headquarters
Austin, Texas
HeadquartersAustin, Texas
Founded
2005
Founded2005
Employees
281
Employees281

APEN Key Statistics

Market cap
419.84M
Market cap419.84M
Price-Earnings ratio
-10.21
Price-Earnings ratio-10.21
Dividend yield
Dividend yield
Average volume
595.97K
Average volume595.97K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$10.30
52 Week high$10.30
52 Week low
$3.49
52 Week low$3.49
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.